WallStreetZenWallStreetZen

NASDAQ: ANIK
Anika Therapeutics Inc Stock Ownership - Who owns Anika Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Anika Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Cheryl R. BlanchardPresident CEO Director2024-03-1114,534$25.79
$374.83kSell
Cheryl R. BlanchardPresident CEO Director2024-03-116,473$25.42
$164.54kSell
Cheryl R. BlanchardPresident CEO Director2024-03-116,973$25.42
$177.25kSell
David ColleranEVP General Counsel Corp Sec2024-03-112,250$25.79
$58.03kSell
David ColleranEVP General Counsel Corp Sec2024-03-111,605$25.42
$40.80kSell
David ColleranEVP General Counsel Corp Sec2024-03-111,081$25.42
$27.48kSell
Anne NunesSVP Chief Operations Officer2024-03-11752$25.79
$19.39kSell
Anne NunesSVP Chief Operations Officer2024-03-11968$25.42
$24.61kSell
Michael L. LevitzEVP CFO Treasurer2024-03-112,610$25.79
$67.31kSell
Michael L. LevitzEVP CFO Treasurer2024-03-111,725$25.42
$43.85kSell

1 of 2

ANIK insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ANIK insiders and whales buy or sell their stock.

ANIK Shareholders

What type of owners hold Anika Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Trigran Investments Inc14.40%2,139,054$54.72MInstitution
Farmaceutici Spa Fidia9.58%1,422,384$36.38MInsider
Blackrock Inc9.32%1,383,877$35.40MInstitution
Caligan Partners LP7.28%1,081,360$27.66MInstitution
Dimensional Fund Advisors LP5.53%821,452$21.01MInstitution
Vanguard Group Inc5.15%764,045$19.54MInstitution
Renaissance Technologies LLC3.80%564,329$14.44MInstitution
Boothbay Fund Management LLC3.43%509,522$13.03MInstitution
Morgan Stanley3.27%485,093$12.41MInstitution
Capital Management Corp2.39%355,534$9.09MInstitution

1 of 3

ANIK vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ANIK84.64%15.36%Net SellingNet Selling
NPCE29.97%70.03%Net SellingNet Selling
MXCT62.67%11.15%Net BuyingNet Buying
SRDX62.61%37.39%Net SellingNet Buying
PACB92.99%7.01%Net BuyingNet Buying
View Top Medical Device Stocks

Anika Therapeutics Stock Ownership FAQ

Who owns Anika Therapeutics?

Anika Therapeutics (NASDAQ: ANIK) is owned by 89.22% institutional shareholders, 16.20% Anika Therapeutics insiders, and 0.00% retail investors. Farmaceutici Spa Fidia is the largest individual Anika Therapeutics shareholder, owning 1.42M shares representing 9.58% of the company. Farmaceutici Spa Fidia's Anika Therapeutics shares are currently valued at $36.37M.

If you're new to stock investing, here's how to buy Anika Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.